Header cover image

South Korean (KOSPI) Healthtech Industry Analysis

UpdatedNov 20, 2024
DataAggregated Company Financials
Companies12
  • 7D32.4%
  • 3M17.2%
  • 1Y-34.4%
  • YTD-30.2%

In the last week, the Healthtech industry is up 23%, with Lunit up 53%. In the same time, LifeSemantics was down 24%. In contrast, the industry has lost 38% in the last 12 months. As for the next few years, earnings are expected to grow by 105% per annum.

Industry Valuation and Performance

Has the South Korean Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 20 Nov 2024₩3.1t₩513.2b-₩83,016,859,320.0012.7x-37.5x6.1x
Fri, 18 Oct 2024₩2.5t₩504.1b-₩85,882,642,230.0013.1x-29x4.9x
Sun, 15 Sep 2024₩2.4t₩504.1b-₩85,882,642,230.0013.3x-27.7x4.7x
Tue, 13 Aug 2024₩2.4t₩479.3b-₩114,966,911,080.0016.7x-20.9x5x
Thu, 11 Jul 2024₩2.8t₩479.3b-₩114,966,911,080.0017.5x-24x5.7x
Sat, 08 Jun 2024₩3.1t₩480.1b-₩121,015,467,340.0012x-25.6x6.4x
Mon, 06 May 2024₩3.1t₩472.9b-₩116,225,868,680.0012.2x-27x6.6x
Wed, 03 Apr 2024₩3.3t₩472.9b-₩116,225,868,680.0012.8x-28.8x7.1x
Fri, 01 Mar 2024₩3.5t₩466.9b-₩121,958,864,840.0016x-28.7x7.5x
Sun, 28 Jan 2024₩3.8t₩470.3b-₩126,434,108,550.0014.9x-30.2x8.1x
Tue, 26 Dec 2023₩4.4t₩473.1b-₩129,782,846,150.0014.1x-33.6x9.2x
Thu, 23 Nov 2023₩4.1t₩473.0b-₩129,648,870,530.0016.5x-31.6x8.7x
Sat, 21 Oct 2023₩3.2t₩472.1b-₩129,827,783,480.0014.9x-25x6.9x
Mon, 18 Sep 2023₩4.7t₩468.0b-₩119,615,334,030.0017.7x-39.6x10.1x
Wed, 16 Aug 2023₩3.9t₩460.8b-₩96,255,067,860.0017.2x-40.7x8.5x
Fri, 14 Jul 2023₩4.0t₩460.8b-₩96,255,067,860.0019.2x-41.6x8.7x
Sun, 11 Jun 2023₩2.9t₩470.4b-₩94,103,710,740.0019x-30.3x6.1x
Tue, 09 May 2023₩2.1t₩454.8b-₩121,205,489,640.0083.1x-17.3x4.6x
Thu, 06 Apr 2023₩2.0t₩454.8b-₩121,205,489,640.0091.8x-16.2x4.3x
Sat, 04 Mar 2023₩2.1t₩446.2b-₩100,021,271,520.0025.5x-21.3x4.8x
Mon, 30 Jan 2023₩1.9t₩448.5b-₩95,899,607,010.0026.6x-20.2x4.3x
Wed, 28 Dec 2022₩1.5t₩448.5b-₩95,899,607,010.0022.8x-16x3.4x
Fri, 25 Nov 2022₩1.6t₩448.6b-₩88,187,335,390.0021.8x-17.9x3.5x
Sun, 23 Oct 2022₩1.1t₩437.6b-₩42,477,231,270.0018x-25.8x2.5x
Tue, 20 Sep 2022₩1.2t₩437.6b-₩42,477,231,270.0019.9x-28.3x2.7x
Thu, 18 Aug 2022₩1.4t₩433.8b-₩36,565,870,330.0024.6x-39x3.3x
Sat, 16 Jul 2022₩1.3t₩433.8b-₩36,565,870,330.0024.7x-36.5x3.1x
Mon, 13 Jun 2022₩1.6t₩424.4b-₩29,952,843,950.0027.9x-53.9x3.8x
Wed, 11 May 2022₩1.7t₩417.0b-₩10,940,781,310.0028x-154.6x4.1x
Fri, 08 Apr 2022₩1.9t₩417.0b-₩10,940,781,310.0030.7x-171.8x4.5x
Sun, 06 Mar 2022₩1.8t₩410.7b-₩19,783,196,720.0036.6x-91.1x4.4x
Tue, 01 Feb 2022₩1.8t₩410.6b-₩18,656,947,590.0035.2x-96.4x4.4x
Thu, 30 Dec 2021₩2.0t₩410.6b-₩18,656,947,590.0040.4x-109.9x5x
Sat, 27 Nov 2021₩2.0t₩408.7b-₩6,856,516,160.0037.1x-284.7x4.8x
Price to Earnings Ratio

-284.7x


Total Market Cap: ₩2.0tTotal Earnings: -₩6,856,516,160.00Total Revenue: ₩408.7bTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Healthtech Industry Price to Earnings3Y Average -46.3x202220232024
Current Industry PE
  • Investors are relatively neutral on the South Korean Healthcare Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-0.72%
Healthcare-4.33%
Healthtech32.43%
Healthtech32.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A328130 Lunit₩64.50k59.7%
+₩697.5b
-28.6%PS71.7x
A311690 CJ Bioscience₩14.78k58.9%
+₩49.9b
-4.2%PS27.5x
A322510 JLKInc₩8.17k21.9%
+₩36.9b
-56.7%PS126.9x
A315640 DEEPNOID₩6.62k24.9%
+₩29.6b
-43.4%PS16x
A226330 SyntekaBio₩6.85k23.6%
+₩20.0b
-39.7%PS840.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.